About Contact Us Careers

Finasteride Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 2984
Published Date: Sep 03, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Finasteride Landscape

Novartis International AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Merck Sharp & Dohme Corp.
Teva Pharmaceuticals Limited
RelconChem Limited
Cipla Ltd.
Zhejiang CONBA Pharmaceutical
Actavis Pharmaceutical Company
Dr. Reddy's Laboratories
Henan Topfond Pharmaceutical Co., Ltd
Guangdong Eashu Pharmaceutical

Browse Key Market Insights with Data Illustration:

Finasteride Market Size & Share, Growth Report 2036

In the News

· May 2021: The U.S. Federal Drug Administration (FDA) accepted the application for usage of tadalafil and finasteride as a combination capsule for the treatment of patients with benign prostatic hyperplasia (BPH).

Author Credits: Radhika Pawar

Report ID: 2984
Published Date: Sep 03, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of finasteride is estimated at USD 111.87 million.

Finasteride Market size was over USD 109.5 million in 2023 and is anticipated to reach USD 154.82 million by 2036, growing at around 2.7% CAGR during the forecast period i.e., between 2024-2036. The market growth is impelled by increasing occurrence of hair loss and prostate cancer and growing R&D activities in the pharmaceutical sector.

Asia Pacific is set to hold largest revenue share by 2036, on the back of growing penetration of finasteride in developing and under-developing countries.

The major players in the market are Novartis International AG, Merck Sharp & Dohme Corp., Teva Pharmaceuticals Limited, RelconChem Limited, Cipla Ltd., and others.

Inquiry Before Buying Request Free Sample